New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Spring, summer births linked to development of pollinosis

Spring, summer births linked to development of pollinosis

by Elana GotkineSpring and summer births are associated with development of pollinosis and summer births are associated with house dust mite (HDM) sensitization, according to a study published in the
Immunology & Rheumatology March 02,2024
Spring, summer births linked to development of pollinosis

Spring, summer births linked to development of pollinosis

by Elana GotkineSpring and summer births are associated with development of pollinosis and summer births are associated with house dust mite (HDM) sensitization, according to a study published in the
Immunology & Rheumatology March 02,2024
VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages
Immunology & Rheumatology March 02,2024
VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages
Immunology & Rheumatology March 02,2024
Unlocking how the new Alzheimer's drug lecanemab works

Unlocking how the new Alzheimer's drug lecanemab works

by Rockefeller UniversityA false-color SEM image of a fibrin blood clot before and after the buildup of amyloid-beta proteins called protofibrils. Credit: Pradeep Singh, PhD; Images collected at
Neurology March 02,2024
Unlocking how the new Alzheimer's drug lecanemab works

Unlocking how the new Alzheimer's drug lecanemab works

by Rockefeller UniversityA false-color SEM image of a fibrin blood clot before and after the buildup of amyloid-beta proteins called protofibrils. Credit: Pradeep Singh, PhD; Images collected at
Neurology March 02,2024
Tips to protect long-term brain health

Tips to protect long-term brain health

by Tufts UniversityCredit: AI-generated imageThere is a growing understanding of the role lifestyle choices play in preventing and slowing the progression of cognitive decline. While we await new
Neurology March 02,2024
Tips to protect long-term brain health

Tips to protect long-term brain health

by Tufts UniversityCredit: AI-generated imageThere is a growing understanding of the role lifestyle choices play in preventing and slowing the progression of cognitive decline. While we await new
Neurology March 02,2024
Using focused ultrasound to treat Alzheimer's and Parkinson's

Using focused ultrasound to treat Alzheimer's and Parkinson's

by Holly Evarts,Columbia University School of Engineering and Applied ScienceMRI and PET scans of an Alzheimer's patient receiving FUS in a small region of the brain (A) with MRI scans deter
Neurology March 02,2024
Using focused ultrasound to treat Alzheimer's and Parkinson's

Using focused ultrasound to treat Alzheimer's and Parkinson's

by Holly Evarts,Columbia University School of Engineering and Applied ScienceMRI and PET scans of an Alzheimer's patient receiving FUS in a small region of the brain (A) with MRI scans deter
Neurology March 02,2024
The biggest financial, legal and functional challenges of caregivers of persons living with dementia

The biggest financial, legal and functional challenges of caregivers of persons living with dementia

by Ann Kellett,Texas A&M UniversityCredit: Pixabay/CC0 Public DomainAnew studypublished inJMIR Agingidentifies the major challenges and needs of the 11 million Americ
Neurology March 02,2024
The biggest financial, legal and functional challenges of caregivers of persons living with dementia

The biggest financial, legal and functional challenges of caregivers of persons living with dementia

by Ann Kellett,Texas A&M UniversityCredit: Pixabay/CC0 Public DomainAnew studypublished inJMIR Agingidentifies the major challenges and needs of the 11 million Americ
Neurology March 02,2024
Researchers identify new gene mutation that alters Alzheimer's disease risk

Researchers identify new gene mutation that alters Alzheimer's disease risk

by Indiana University School of MedicineGraphical Abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.08.008A study led by experts from Indiana University School of Medicine h
Neurology March 02,2024
Researchers identify new gene mutation that alters Alzheimer's disease risk

Researchers identify new gene mutation that alters Alzheimer's disease risk

by Indiana University School of MedicineGraphical Abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.08.008A study led by experts from Indiana University School of Medicine h
Neurology March 02,2024
Could a breakdown in the brain's networks allow infections to contribute to Alzheimer's disease?

Could a breakdown in the brain's networks allow infections to contribute to Alzheimer's disease?

by Drexel UniversityCartoon of the LDA algorithm. Credit:Frontiers in Cellular and Infection Microbiology(2023). DOI: 10.3389/fcimb.2023.1123228The human microbiome includes the genet
Neurology March 02,2024
Could a breakdown in the brain's networks allow infections to contribute to Alzheimer's disease?

Could a breakdown in the brain's networks allow infections to contribute to Alzheimer's disease?

by Drexel UniversityCartoon of the LDA algorithm. Credit:Frontiers in Cellular and Infection Microbiology(2023). DOI: 10.3389/fcimb.2023.1123228The human microbiome includes the genet
Neurology March 02,2024
New research reveals link between finger tapping and Alzheimer's

New research reveals link between finger tapping and Alzheimer's

by Leiden UniversityCredit: Unsplash/CC0 Public DomainSuddenly getting lost, failing to recognize family members, or forgetting words and names are well-known symptoms of Alzheimer's disease.
Neurology March 02,2024
New research reveals link between finger tapping and Alzheimer's

New research reveals link between finger tapping and Alzheimer's

by Leiden UniversityCredit: Unsplash/CC0 Public DomainSuddenly getting lost, failing to recognize family members, or forgetting words and names are well-known symptoms of Alzheimer's disease.
Neurology March 02,2024
Study discovers possible tool to diagnose common contributor to vascular dementia

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW
Neurology March 02,2024
Study discovers possible tool to diagnose common contributor to vascular dementia

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW
Neurology March 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com